Please login to read the full article.
Scrip Regulatory Affairs
US transparency proposals may hurt device firms, industry warns
23 July 2010
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- EU medtech report calls for randomised clinical trials and centralised pre-market evaluation
- US lawmaker seeks to streamline FDA's medical device approval process
- US FDA device reviewers to use new worksheet from 1 May to capture benefit-risk determinations
- US FDA's de novo proposal will not result in significant time saving, says medtech association
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
